Skip to search formSkip to main contentSkip to account menu

pyrazolopyrimidine

National Institutes of Health

Related topics

Related topics

4 relations

Narrower (2)

AllopurinolFormycins

Broader (2)

PyrimidinePyrimidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Evaluation of pyrazolopyrimidine derivatives as microtubule affinity regulating kinase 4 inhibitors: Towards therapeutic management of Alzheimer’s disease
Abstract Microtubule affinity regulating kinase 4 (MARK4) plays essential role in the tau-assisted regulation of microtubule… 
Highly Cited
2019
Highly Cited
2019
Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4)
Microtubule affinity-regulating kinase 4 (MARK4) has recently been identified as a potential drug target for several complex… 
Highly Cited
2014
Highly Cited
2014
Development of potent and selective Plasmodium falciparum calcium-dependent protein kinase 4 (PfCDPK4) inhibitors that block the transmission of malaria to mosquitoes.
Highly Cited
2008
Highly Cited
2008
Isolation and identification of thiohomosildenafil and thiosildenafil in health supplements.
Highly Cited
2005
Highly Cited
2005
Synthesis and in vivo evaluation of a novel peripheral benzodiazepine receptor PET radioligand.
Highly Cited
2005
Highly Cited
2005
Regulation of aryl hydrocarbon receptor signal transduction by protein tyrosine kinases.
Highly Cited
2004
Highly Cited
2004
Mechanical Strain on Osteoblasts Activates Autophosphorylation of Focal Adhesion Kinase and Proline-rich Tyrosine Kinase 2 Tyrosine Sites Involved in ERK Activation*
The mechanisms involved in the mechanical loading-induced increase in bone formation remain unclear. In this study, we showed… 
Highly Cited
2002
Highly Cited
2002
Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes.
Highly Cited
2000
Highly Cited
2000
Pharmacokinetics, pharmacodynamics, and relative pharmacokinetic/pharmacodynamic profiles of zaleplon and zolpidem.
Review
1988
Review
1988
Adenosine antagonists as potential therapeutic agents
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)